TrialAnnals of the rheumatic diseases2021

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.

Stanley B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.